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ABSTRACT  Refractory ceramic fibers (RCFs) are one of the many man-made mineral fibers 
(MMMFs) / synthetic vitreous fibers (SVFs) used as alternative products to asbestos fibers. 
The Japanese Ministry of Health, Labour and Welfare began to regulate the manufacturing 
and handling of RCFs under specific chemical disorder prevention rules to reduce the risks of 
exposure to RCFs since November 1st, 2015. In fact, the International Agency for Research 
on Cancer (IARC) categorized RCFs as group 2B, being possibly carcinogenic to humans, 
according to results obtained from animal experiments. Thus, given the biological effects of 
RCFs previously reported in the literature, it is necessary to consider further monitoring in 
addition to the development of measures to prevent adverse health effects caused by exposure 
to RFCs. In this review, a summary of the biological effects of refractory ceramic fibers (RCFs) 
is presented and discussed with respect to toxicity, animal models and epidemiological studies, 
and a comparison is made with asbestos exposure to outline and clarify the current status 
pertaining to the biological effects of RCFs. doi：10.11482/KMJ-E41（2）57　(Accepted on October 6, 2015)
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〈Review〉
INTRODUCTION
   Asbestos fibers cause various human diseases 
such as lung fibrosis, pleural plaque, pleural 
thickening, and cancers (lung cancer and malignant 
mesothelioma)１－５）. Thus, the use of asbestos has 
been banned in many countries including Japan. 
However, since the latency period for the occurrence 
of malignant mesothelioma (MM) is assumed to be 
30 to 50 years, and the prognosis of MM is poor, 
with a median survival time of less than one year, 
it is necessary to develop better tools for early 
diagnosis and treatment, in addition to strategies 
that prevent the occurrence of MM６－９）.
   On the other hand, many man-made mineral 
fibers (MMMFs) / synthetic vitreous fibers (SVFs) 
have been used in the industrial field as alternative 
products to asbestos10－13）.
   Among the MMMFs, refractory ceramic fibers 
(RCFs; CAS no. 142844-00-6), also referred to 
as aluminosilicate wools (ASWs), are amorphous 
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fibers that possess several features such as high-
temperature insulation, resistance to thermal 
shock, light weight, and corrosion resistance. The 
chemical composition comprises 30-60% Al2O3, 
40-60% SiO2 and 0-20% RnOm (R is Cr or Z)
14－16）. 
However, the safe usage and production of RCFs 
should be considered since there is a fear of adverse 
biological effects given the fibrous characteristics. 
In fact, the International Agency for Research on 
Cancer (IARC) categorized RCFs as group 2B, 
being possibly carcinogenic to humans, according 
to results obtained from animal experiments17）. 
Moreover, the Japanese Ministry of Health, 
Labour and Welfare regulates the manufacturing 
and handling of RCFs under the specific chemical 
disorder prevention rules to reduce the risks of 
exposure to RCFs since November 1st, 201518）.
   At this point, it will be important to summarize 
the biological effects of RCFs to establish a 
better understanding for the prevention of excess 
exposure to RCFs in workers involved in the RCF 
manufacturing industry.
Biopersistence
   Several reports have described the biopersistence 
of SVFs and amosite asbestos in the rat lung 
following inhalation, since the toxicity of fibers is 
mainly dependent on the concentrations in the body, 
dimension of the fibers (length, width, thickness 
and aspect ratio) and biopersistence15，19－21）. From 
these reports, the durability of RCFs expressed as 
Kdis (ng/cm
2/h); kinetic constant for dissolution) 
was reported as 8.015，21）. Since the durability of 
crocidolite was reported as 0.3, RCFs possess 
relatively lower durability than asbestos fibers, 
however, they possess higher durability than other 
SVFs such as rockwool and glasswool. Additionally, 
although many reports have shown results with 
respect to biopersistence, detailed methods of 
exposure such as duration are lacking. However, 
taken together with the many reports15，19－22）, it 
is clear that RCFs possess significantly lower 
bioresistence compared to asbestos fibers, but 
greater bioresistence compared to other SVFs. 
Toxicological bioassays in animals
   Bioassays using animals are usually performed 
by intraperitoneal implantation23－25）, intrapleural 
implantation16，25）, intratracheal instillation26） and 
chronic inhalation23－29）. Although the length and 
doses of fibers and experimental animals (Wistar 
rats, Osborne-Mendel rats and Syrian golden 
hamsters) varied, the intraperitoneal23－25） and 
intrapleural implantation16，25） methods yielded 
mesothelioma, sarcoma and adenoma. Intratracheal 
studies also showed the occurrence of lung tumors 
such as adenoma, carcinoma and mesothelioma, 
even though the incidence was lower than 
that observed with the implantation studies26）. 
Additionally, results of studies involving chronic 
inhalation varied, from no pulmonary tumors being 
observed to the occurrence of tumors including 
pulmonary adenoma, carcinoma, and pleural 
mesothelioma23－29）. 
   However, there are certain criticisms regarding 
animal  s tudies.  For example,  al though the 
intraperitoneal and intrapleural implantation 
methods may be useful in exploring fiber-related 
carcinogenic mechanisms, the relevance to human 
exposure conditions has not been delineated. 
Additionally, there is the possibility of over-loading 
animals with the fibers. As mentioned above, since 
the durability and biopersistence of fibers are 
important factors in the evaluation of toxicity, it is 
very difficult to apply the results of animal models 
to the occupational exposure of humans to fibers. 
   Given  tha t  regula tory  ru les  need  to  be 
implemented to protect the health of workers, 
and due consideration be given to the variety of 
occupational sites and exposure situations that 
exist, it is inappropriate to simply wait for the 
appearance of adverse effects in workers before 
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regulations are formulated and enacted. Thus, the 
results from animal models investigating fibers 
and various chemicals should be considered in the 
categorization of harmful effects, especially in terms 
of carcinogenesis.
Epidemiological studies
   RCFs were initially commercialized during the 
1950s in the United States, late 1960s in Europe, 
middle of the 1970s in South Africa and Australia, 
and then spread to the rest of the world30）. As 
mentioned above, in addition to the results of animal 
model studies demonstrating the carcinogenic 
effects of RCFs, some epidemiological studies were 
performed.
   The initial cross-sectional study in the U.S. showed 
that significantly higher pulmonary symptoms such 
as dyspnea were present in production workers 
compared to non-production workers in the RCF 
handling and manufacturing industries31）. The 
incidence of pulmonary symptoms was 29.6% 
in production workers and 11.3% in the non-
production population with a significant odd ratio 
of 2.9 (Confidence interval (CI) : 1.4-6.2). Other 
studies also represented the relationship between 
recent exposure and dry cough, nasal obstruction 
and stimulatory symptoms in eye and skin, a positive 
relationship between RCF exposure and dyspnea, 
and a relationship between accumulative exposure 
and various pulmonary disorders including chronic 
bronchitis, dyspnea, recurrent respiratory diseases, 
and pleural pain. Regarding pulmonary function 
examinations, although forced expiratory volume 
in one second (FEV1.0) was the same for production 
workers and the non-production population, forced 
vital capacity ‘FVC) was lower in RCF production 
workers compared to present or past smokers. The 
decrease in FVC in fiber-handling workers was not 
specific for RFCs. It has also been reported in the 
asbestos-handling population32）. Additionally, one 
report using a rat model demonstrated that RCFs 
and tobacco smoke additively induced cellular 
toxicity in the lung33）.
   Regarding pleural plaque and fibrotic changes 
in the lung interstitium, although insufficient 
epidemiological studies have been performed, 
accumulat ive exposure to RCFs seemed to 
induce pleural changes diagnosed by radiological 
examination every three years34）. However, these 
reports failed to detail the interstitial changes of the 
lung. Another study also showed the occurrence of 
pleural plaque in workers handling RCFs35）. 
What about carcinogenesis?
   Relatively few studies have demonstrated the 
occurrence of lung cancers in workers exposed to 
RCFs, and no statistically significant relationship 
was found between the occurrence of lung cancer 
and exposure to RCFs36－40）. 
   However, there is one report of interest regarding 
the mortality of workers that handled RCFs39）. 
Among the deaths, heart disease, respiratory system 
diseases, digestive system diseases, accidents, 
violence, and cancers including total cancers, 
digestive, respiratory, urinary and other sites, only 
cancer in urinary organs showed significant high 
mortality with a 344.8 standardized mortality ratio 
(SMR; 95% CI: 111.6-805.4), although there were 
no excess mortality in all deaths, cancers, and 
respiratory diseases including mesothelioma. There 
is no immediate explanation to account for the 
excess death involving urinary cancer in the RCF-
exposed population, and further studies are required.
Other biological effects of RCFs 
   Regarding other cellular and molecular biological 
effects of RCFs, there are some reports that have 
focused on the immune system, since the immune 
system particularly in the lung is important as the 
initial response to recognize foreign substances 
entering the body. 
   Using rat alveolar macrophages exposed in vitro to 
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various fibers including crocidolite, RCF, silica and 
titanium dioxide (TiO2) as the control, Leikauf et al. 
studied the release of eicosanoids and cytokines41）. 
RCF induced the release of eicosanoids and tumor 
necrosis factor (TNF), although the extent of the 
release was lower compared to that of macrophages 
exposed to crocidolite. 
   Morimoto et al. examined mRNA expression 
in rat alveolar macrophages exposed to various 
mineral fibers and tobacco smoke42）. They showed 
an enhancement in mRNA expression of interleukin 
(IL)-1α by cigarette smoke, IL-1α，IL-6 and 
TNFα by chrysotile asbestos, inducible nitric oxide 
synthase (iNOS), IL-6 and basic fibroblast growth 
factor (bFGF) by chrysotile with cigarette smoke, 
in addition to IL-1α and TNFα by RCF, and IL-1α 
and bFGF by RCF with cigarette smoke. Since 
cytokines such as IL-1α，iNOS and bFGF are 
known to play an important role in remodeling of 
the lung, these cytokines may be important in cases 
of lung injury and remodeling caused by exposure 
to mineral fibers.
   Additionally, Tulnska et al. performed intratracheal 
instillation of RCF (1 mg/animal) using male 
Sprague Dawley rats43）. They showed a proliferative 
response in spleen T cells caused by mitogen, and T 
cell-dependent B cell activation induced by mitogen 
was lower compared to control animals.
   Moreover, we also reported apoptosis in human 
peripheral blood mononuclear cells (PBMCs) 
caused by various MMMFs including RCF44）. This 
report showed that apoptosis in PBMCs was caused 
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by chrysotile asbestos as well as other MMMFs 
such as RCF, rockwool, glasswool and wollastorite, 
with overexpression of apoptosis-related genes.  The 
degree of occurrence and level of gene expression 
induced by RCFs were lower compared to 
chrysotile, but greater than other fibers.
   Taken together with these studies, the immunological 
effects of RCFs may be intermediate, although 
lower than that of asbestos and greater than in 
the case of other SVFs. Our laboratory has been 
investigating the immunological effects of asbestos 
fibers and found a reduction in anti-tumor immunity 
in T cells, natural killer cells, and CD8-positive 
cytotoxic T cells. Further studies are needed to 
elucidate the alteration in anti-tumor immunity 
caused by exposure to RCFs.
CONCLUSION
   Given the impending enforcement of the law 
regarding the specific chemical disorder prevention 
rules to reduce the risks of exposure to RCFs from 
November 1st, 2015, the biological effects of RCFs 
should be carefully monitored and explored since 
we have to avoid the same disaster that occurred 
as a result of exposure to asbestos. For example, 
radiological monitoring of workers handling 
RCFs for manufacturing needs to be performed, 
in addition to checking the past chest X-P taken 
in standard medical check-ups from the viewpoint 
of pneumoconiosis monitoring. Moreover, cellular 
and molecular studies should be performed to 
detect any adverse effects of RCFs, and if present, 
facilitate the development of strategies that prevent 
carcinogenesis caused by exposure to RCFs.
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